Sign In
Buy PPH
$110.40
-1.20 (-1.08%)
At Close: Jul 31, 2026
3 Best Healthcare Stocks: Quant Strong Buys From Goldman's 'Alpha' List
04:05pm, Monday, 17'th Nov 2025
The healthcare sector's renewed momentum offers fertile ground for investors wanting to outperform by picking the best stocks from the broader indexes. Goldman Sachs identified 29 healthcare stocks in
Top Pharmaceutical Companies Shaping the Future of Healthcare
08:04am, Saturday, 01'st Nov 2025
Pharma's strong pipelines, reduced policy risks, and demand growth drive renewed investor interest. PPH offers targeted access to top innovators like Eli Lilly and Merck.
Drug Stocks Just Had Their Best Week in 2 Decades. Should You Invest?
06:10am, Monday, 13'th Oct 2025
Pharmaceutical stocks are having a moment. The S&P 500 Pharmaceuticals Index recently rose 11% during five trading days, its best weekly gain since 2022.
4 Reasons to Buy Pharma ETFs Now for a Healthy Portfolio
08:01am, Monday, 06'th Oct 2025
Pharma's Trump-Pfizer boost sparks momentum, making ETFs PPH, IHE, PJP & XPH attractive for defensive, undervalued growth plays.
Trump announces 100% tariffs on pharmaceutical drugs, beginning October 1
01:22pm, Friday, 26'th Sep 2025
President Donald Trump said Thursday that he will put import taxes of 100% on pharmaceutical drugs, 50% on kitchen cabinets and bathroom vanities, 30% on upholstered furniture and 25% on heavy trucks
Trump Slams 100% Tariff on Imported Drugs: Pharma ETFs Take a Hit
10:26am, Friday, 26'th Sep 2025
Trump's 100% tariff on imported drugs jolts markets, slamming pharma giants and dragging ETFs like XPH, FTXH, IHE, and PPH lower.
Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
07:21am, Monday, 22'nd Sep 2025
If you're interested in broad exposure to the Healthcare - Pharma segment of the equity market, look no further than the VanEck Pharmaceutical ETF (PPH), a passively managed exchange traded fund launc
PPH: Excellent Pharmaceutical ETF, But Bad Timing To Invest
08:52am, Thursday, 18'th Sep 2025
VanEck Pharmaceutical ETF offers focused exposure to large-cap pharmaceutical companies, benefiting from strong long-term demographic and innovation trends. PPH's high concentration in top holdings an
Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
07:21am, Tuesday, 22'nd Jul 2025
If you're interested in broad exposure to the Healthcare - Pharma segment of the equity market, look no further than the VanEck Pharmaceutical ETF (PPH), a passively managed exchange traded fund launc
PPH: Global Pharma Stocks Continue To Face Headwinds, Tariffs Front And Center
08:23pm, Monday, 07'th Jul 2025
I maintain a hold rating on PPH due to attractive valuation but weak technical momentum and underperformance versus the S&P 500. Eli Lilly and Johnson & Johnson, PPH's largest holdings, are facing uni
Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
07:20am, Wednesday, 21'st May 2025
The VanEck Pharmaceutical ETF (PPH) was launched on 12/20/2011, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Pharma segment of the equity market
ETFs on the Move Post U.S.-China Trade Deal
01:55pm, Monday, 12'th May 2025
Let's delve into the ETF world following the 90-day U.S.-China trade deal.
A Look at Pharma ETFs After Strong Q1 Earnings
12:50pm, Thursday, 08'th May 2025
Many pharma bigwigs reported solid results, with some beating on earnings or revenues or both.
PPH: Will Overcome Tariffs, But Competitor Funds Look Stronger
09:15am, Monday, 14'th Apr 2025
VanEck Pharmaceutical ETF holds a mixed outlook due to high fees and tariff risks, warranting a hold rating despite strong top holdings. PPH's top holdings like Eli Lilly and Johnson & Johnson have di
Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
07:21am, Thursday, 20'th Mar 2025
Looking for broad exposure to the Healthcare - Pharma segment of the equity market? You should consider the VanEck Pharmaceutical ETF (PPH), a passively managed exchange traded fund launched on 12/20/
